Nonetheless, given that treatment of RCC cell lines, with elevated AURKA expression, using NVP-BEZ235 showed decreased AURKA expression (Fig. 2F), we wanted to correlate this decrease in AURKA expression to reduced tumor burden in an in vivo model of RCC. The gene discussed is AURKA; the disease is neoplasm.